MRC-5 is a diploid cell line d in the production of vaccines, including hepatitis A, polio, and MCR-5, and is made up of fibroblasts isolated from the lung tissue derived from a White, male, 14-week-old embryo by J.P. Jacobs in 1966. The cells are capable of 42 to 46 population doublings.